Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) hit a new 52-week high during trading on Thursday . The company traded as high as $15.14 and last traded at $15.07, with a volume of 140203 shares trading hands. The stock had previously closed at $13.86.
Analysts Set New Price Targets
RBGLY has been the subject of a number of recent research reports. Royal Bank Of Canada reiterated an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday. Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and four have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy".
Read Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Down 0.2%
The company has a debt-to-equity ratio of 1.08, a quick ratio of 0.39 and a current ratio of 0.58. The firm's 50-day simple moving average is $13.76 and its 200-day simple moving average is $13.30.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access